Louis J. Vollmer Named Iroko’s CEO
Iroko Pharmaceuticals LLC. has appointed Louis J. Vollmer president and CEO. Vollmer has been president of Iroko since March 2015 and continues as a member of the company’s board of directors. He succeeds as CEO Osagie Imasogie, Iroko’s founder, who will continue as the company’s chair. Vollmer started his career at DuPont Merck where he ultimately served as vice president of sales and marketing for DuPont Multi Source Products.
You may also be interested in...
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.